Dr. Todd V. Brennan, MD

Dr. Brennan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Brennan's NPI, 1679612907, was assigned on February 5, 2007. Dr. Brennan graduated from Harvard Medical School in 1999. Dr. Brennan's California license number on file is A75140.

Dr. Brennan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Brennan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Brennan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brennan practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Brennan's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Brennan is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Brennan's licenses on file in 2 states: California and North Carolina.

CMS data shows 113 Medicare services from Dr. Brennan across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $72,409 for them.

CMS counts 91 Medicare patients who saw Dr. Brennan in 2024. The largest group is under 65, with 53 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 9.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brennan's median patient age at 59, with 31% women.

In 2022, Dr. Brennan wrote 47 Medicare Part D claims. They cover 2 drugs, with $502 in total drug cost. In 2021, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Brennan for performance year 2024, reported as part of a group. Dr. Brennan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 63 papers to Dr. Brennan, published from 2006 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Graft Rejection, Mice, Inbred C57BL and Kidney Transplantation. Dr. Brennan has published most often in Am J Transplant. Dr. Brennan's most frequent co-authors are Andrew Serghios Barbas, MD, Tsuyoshi Todo, MD and Sandy Feng, MD.

CMS Open Payments shows 6 general payments to Dr. Brennan from 5 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 86% of the total. Pfizer Inc. paid the most, $3,200.

Dmand AI lists 1 award for Dr. Brennan.

Dr. Brennan graduated from Harvard Medical School in 1999. Dr. Brennan is a member of ACS.

Dr. Brennan is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.